Interactions among type I and type II interferon, tumor necrosis factor, and β-estradiol in the regulation of immune response-related gene expressions in systemic lupus erythematosus
Open Access
- 1 January 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in Arthritis Research & Therapy
- Vol. 11 (1), R1
- https://doi.org/10.1186/ar2584
Abstract
No abstract availableThis publication has 35 references indexed in Scilit:
- Abnormal expression of the genes involved in cytokine networks and mitochondrial function in systemic juvenile idiopathic arthritis identified by DNA microarray analysisAnnals Of The Rheumatic Diseases, 2008
- Up-regulated expression of Toll-like receptors mRNAs in peripheral blood mononuclear cells from patients with systemic lupus erythematosusClinical and Experimental Immunology, 2008
- Toll-like receptors and innate immune responses in systemic lupus erythematosusArthritis Research & Therapy, 2007
- Effects of short-term infliximab therapy on autoantibodies in systemic lupus erythematosusArthritis & Rheumatism, 2006
- Toll‐Like Receptor Activation in the Pathogenesis of Systemic Lupus ErythematosusAnnals of the New York Academy of Sciences, 2005
- Role of Fcγ receptor IIb polymorphism in the genetic background of systemic lupus erythematosus: Insights from AsiaAutoimmunity, 2005
- Toll-like receptors stimulate human neutrophil functionBlood, 2003
- Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus BloodThe Journal of Experimental Medicine, 2003
- THE MITOGEN-ACTIVATED PROTEIN KINASE p38 IS NECESSARY FOR INTERLEUKIN-1β-INDUCED MONOCYTE CHEMOATTRACTANT PROTEIN 1 EXPRESSION BY HUMAN MESANGIAL CELLSCytokine, 1999
- Serum Level of Interferon-.GAMMA. in Autoimmune Diseases.The Tohoku Journal of Experimental Medicine, 1991